BTBD9 rs4714156: Understanding Your Genetic Risk for RLS
The rs4714156 variant is a single nucleotide polymorphism located within the BTBD9 gene. Research has identified this specific genetic marker as being associated with a modified risk of developing restless legs syndrome (RLS).
What each genotype means
Increased restless legs risk
Research indicates that individuals with this genotype have a higher statistical association with restless legs syndrome compared to those carrying the T allele. This genotype is considered the higher-risk profile in the context of this specific genetic variant.
This genotype is common, occurring in approximately 25% of the population based on the reported minor allele frequency.
Intermediate risk profile
Carriers of this heterozygous genotype show an intermediate statistical association with restless legs syndrome. The presence of one T allele is associated with a reduced risk compared to the C/C genotype.
This is a very common genotype, found in roughly 50% of the population.
Reduced restless legs risk
This genotype is associated with a reduced risk of developing restless legs syndrome, with studies showing an odds ratio of approximately 0.61 for the T allele. This suggests a protective association relative to the C allele.
This genotype is common, appearing in approximately 25% of the population.
What is the rs4714156 Variant?
The rs4714156 variant is a specific change in the DNA sequence, known as a single nucleotide polymorphism (SNP), located within the BTBD9 gene. In genetics, a SNP represents a variation at a single position in the DNA chain. This particular variant is found in a region of the genome that has been extensively studied for its potential influence on neurological and sleep-related conditions. By analyzing this site, researchers can compare the presence of different alleles—the specific versions of the DNA sequence—across large groups of people to determine if one version is more common in individuals who experience certain health conditions compared to those who do not. Understanding the location and nature of rs4714156 is a foundational step in exploring how subtle variations in our genetic code may contribute to complex traits like sleep patterns and limb movement regulation.
The Role of the BTBD9 Gene
The BTBD9 gene, which stands for BTB domain containing 9, provides instructions for producing a protein whose exact function in the human body is still being actively researched. Scientific studies using animal models, such as fruit flies and mice, have provided significant insights into the potential role of this gene. When the BTBD9 gene is disrupted or removed in these models, the subjects often exhibit behaviors that resemble motor restlessness and sleep disruption. These findings suggest that the BTBD9 protein may play a critical role in the development or maintenance of neurological pathways that regulate movement and sleep cycles. While the precise biological mechanism in humans remains a subject of ongoing investigation, the consistent association between this gene and sleep-related phenotypes across different species highlights its importance in the broader context of neurobiology and sleep health.
Research Associations and Evidence Strength
The association between the BTBD9 gene and restless legs syndrome (RLS) is supported by multiple genome-wide association studies (GWAS). These studies have consistently identified variants within or near the BTBD9 gene that correlate with an increased or decreased risk of RLS and periodic limb movements during sleep. The evidence for this association is generally considered moderate, as it is based on statistical correlations observed in large cohorts rather than a direct, singular cause-and-effect relationship. It is important to note that RLS is a complex condition likely influenced by a combination of multiple genetic factors, environmental triggers, and lifestyle variables. Therefore, while rs4714156 is a recognized marker in the scientific literature, it is only one piece of a much larger genetic puzzle. Researchers continue to refine these findings to better understand how this variant interacts with other genes and external factors to influence individual health outcomes.
Interpreting Your Genetic Information
It is essential to understand that having a specific genotype for rs4714156 does not mean an individual will or will not develop restless legs syndrome. Genetic associations are statistical probabilities observed across populations, not diagnostic tools for individuals. If you are concerned about symptoms such as an overwhelming urge to move your legs, particularly in the evening or while resting, it is important to consult with a healthcare professional. A doctor can evaluate your symptoms, medical history, and lifestyle to provide an accurate assessment and discuss potential management strategies. Genetic information should never be used to self-diagnose or to make medical decisions without the guidance of a qualified clinician. Always prioritize professional medical advice over insights gained from genetic testing, as your overall health is determined by a complex interplay of many factors beyond a single genetic variant.
How common is this variant?
The rs4714156 variant is widely distributed, with a reported minor allele frequency of approximately 0.4991 in many studied populations.
Frequently asked questions
Does having the rs4714156 variant mean I have RLS?
No, this variant is a statistical marker associated with a change in risk, not a diagnostic test. Many people with this variant do not have RLS, and many people with RLS do not carry this specific variant.
Can I use this information to prevent restless legs syndrome?
Genetic variants are inherited and cannot be changed. You should focus on healthy sleep hygiene and consult a doctor if you experience symptoms, as they can provide evidence-based strategies for managing discomfort.
Is BTBD9 the only gene linked to RLS?
No, RLS is a complex condition associated with several different genes, including MEIS1 and MAP2K5/SKOR1. Genetic risk is typically the result of the combined effect of many different variants.
Where can I find more information about my specific genetic results?
You should discuss your genetic reports with a certified genetic counselor or your primary care physician. They can help you interpret the results in the context of your personal and family health history.
Sources & further reading
Educational information only, last refreshed 10/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4714156?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTBD9
Intronic variant strongly associated with restless legs syndrome (RLS) susceptibility and periodic limb movements during sleep (PLMS), mediating altered iron homeostasis.
A prominent non-coding variant in BTBD9 strongly conferring risk for periodic limb movements during sleep and restless legs syndrome.
Genome-wide significant intronic susceptibility variant in BTBD9 strongly predisposing individuals to restless legs syndrome and periodic limb movements in sleep.
A regulatory intron variant in BTBD9 strongly associated with periodic limb movements in sleep and fragmented sleep architecture.
Well-validated intronic risk variant in BTBD9 strongly associated with periodic limb movement in sleep (PLMS) and restless legs syndrome (RLS).
Variant in BTBD9 strongly linked to nocturnal sleep fragmentation, reduced sleep efficiency, and periodic limb movement index during polysomnography.